Literature DB >> 30593263

PAX3-FOXO1 escapes miR-495 regulation during muscle differentiation.

Zhongqiu Xie1, Yue Tang1,2, Xiaohu Su3,4, Junwei Cao1,3,4, Yanru Zhang3,4, Hui Li1,2,5.   

Abstract

Pax3 plays an essential role in myogenesis. Previously, we found a tumor-signature chimeric fusion RNA, PAX3-FOXO1 also present during muscle differentiation, raising the possibility of its physiological role. Here we demonstrated that the fusion is needed transiently for muscle lineage commitment. Interestingly, the fusion ortholog was not found in seven mouse muscle differentiation/regeneration systems, nor in other stem cell differentiation systems of another three mammal species. We noticed that Pax3 is expressed at a much lower level in human stem cells, and during muscle differentiation than in other mammals. Given the fact that the fusion and the parental Pax3 share common downstream targets, we reasoned that forming the fusion may be a mechanism for human cells to escape certain microRNA regulation on Pax3. By sequence comparison, we identified 16 candidate microRNAs that may specifically target the human PAX3 3'UTR. We used a luciferase reporter assay, examined the microRNAs expression, and conducted mutagenesis on the reporters, as well as a CRISPR/Cas9 mediated editing on the endogenous allele. Finally, we identified miR-495 as a microRNA that specifically targets human PAX3. Examining several other fusion RNAs revealed that the human-specificity is not limited to PAX3-FOXO1. Based on these observations, we conclude that PAX3-FOXO1 fusion RNA is absent in mouse, or other mammals we tested, the fusion RNA is a mechanism to escape microRNA, miR-495 regulation in humans, and that it is not the only human-specific fusion RNA.

Entities:  

Keywords:  Chimeric RNA; adipose-derived stroma/stem cells; mesenchymal stem cells; miR-495; microRNA; myogenesis

Mesh:

Substances:

Year:  2019        PMID: 30593263      PMCID: PMC6380322          DOI: 10.1080/15476286.2018.1564464

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  36 in total

1.  Alternative splicing of conserved exons is frequently species-specific in human and mouse.

Authors:  Qun Pan; Malina A Bakowski; Quaid Morris; Wen Zhang; Brendan J Frey; Timothy R Hughes; Benjamin J Blencowe
Journal:  Trends Genet       Date:  2005-02       Impact factor: 11.639

2.  Genome-wide identification of PAX3-FKHR binding sites in rhabdomyosarcoma reveals candidate target genes important for development and cancer.

Authors:  Liang Cao; Yunkai Yu; Sven Bilke; Robert L Walker; Linnia H Mayeenuddin; David O Azorsa; Fan Yang; Marbin Pineda; Lee J Helman; Paul S Meltzer
Journal:  Cancer Res       Date:  2010-07-27       Impact factor: 12.701

3.  c-Myb oncoprotein is an essential target of the dleu2 tumor suppressor microRNA cluster.

Authors:  Elaine Y Chung; Michael Dews; Diana Cozma; Duonan Yu; Erik A Wentzel; Tsung-Cheng Chang; Janell M Schelter; Michele A Cleary; Joshua T Mendell; Andrei Thomas-Tikhonenko
Journal:  Cancer Biol Ther       Date:  2008-11-04       Impact factor: 4.742

4.  Effects of rearrangement and allelic exclusion of JJAZ1/SUZ12 on cell proliferation and survival.

Authors:  Hui Li; Xianyong Ma; Jinglan Wang; Jason Koontz; Marisa Nucci; Jeffrey Sklar
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-06       Impact factor: 11.205

5.  NCLscan: accurate identification of non-co-linear transcripts (fusion, trans-splicing and circular RNA) with a good balance between sensitivity and precision.

Authors:  Trees-Juen Chuang; Chan-Shuo Wu; Chia-Ying Chen; Li-Yuan Hung; Tai-Wei Chiang; Min-Yu Yang
Journal:  Nucleic Acids Res       Date:  2015-10-05       Impact factor: 16.971

6.  Cotranscription and intergenic splicing of human galactose-1-phosphate uridylyltransferase and interleukin-11 receptor alpha-chain genes generate a fusion mRNA in normal cells. Implication for the production of multidomain proteins during evolution.

Authors:  F Magrangeas; G Pitiot; S Dubois; E Bragado-Nilsson; M Chérel; S Jobert; B Lebeau; O Boisteau; B Lethé; J Mallet; Y Jacques; S Minvielle
Journal:  J Biol Chem       Date:  1998-06-26       Impact factor: 5.157

7.  Discovery of CTCF-sensitive Cis-spliced fusion RNAs between adjacent genes in human prostate cells.

Authors:  Fujun Qin; Zhenguo Song; Mihaela Babiceanu; Yansu Song; Loryn Facemire; Ritambhara Singh; Mazhar Adli; Hui Li
Journal:  PLoS Genet       Date:  2015-02-06       Impact factor: 5.917

8.  miR-27b regulates myogenic proliferation and differentiation by targeting Pax3 in goat.

Authors:  Ying-Hui Ling; Meng-Hua Sui; Qi Zheng; Kang-Yan Wang; Hao Wu; Wen-Yong Li; Yong Liu; Ming-Xing Chu; Fu-Gui Fang; Li-Na Xu
Journal:  Sci Rep       Date:  2018-03-02       Impact factor: 4.379

9.  Chimeras taking shape: potential functions of proteins encoded by chimeric RNA transcripts.

Authors:  Milana Frenkel-Morgenstern; Vincent Lacroix; Iakes Ezkurdia; Yishai Levin; Alexandra Gabashvili; Jaime Prilusky; Angela Del Pozo; Michael Tress; Rory Johnson; Roderic Guigo; Alfonso Valencia
Journal:  Genome Res       Date:  2012-05-15       Impact factor: 9.043

10.  Recurrent chimeric fusion RNAs in non-cancer tissues and cells.

Authors:  Mihaela Babiceanu; Fujun Qin; Zhongqiu Xie; Yuemeng Jia; Kevin Lopez; Nick Janus; Loryn Facemire; Shailesh Kumar; Yuwei Pang; Yanjun Qi; Iulia M Lazar; Hui Li
Journal:  Nucleic Acids Res       Date:  2016-02-02       Impact factor: 16.971

View more
  8 in total

1.  Functional heritage: the evolution of chimeric RNA into a gene.

Authors:  Hao Wu; Sandeep Singh; Xinrui Shi; Zhongqiu Xie; Emily Lin; Xiaorong Li; Hui Li
Journal:  RNA Biol       Date:  2019-09-29       Impact factor: 4.652

Review 2.  Chimeric RNAs Discovered by RNA Sequencing and Their Roles in Cancer and Rare Genetic Diseases.

Authors:  Yunan Sun; Hui Li
Journal:  Genes (Basel)       Date:  2022-04-22       Impact factor: 4.141

3.  NLRP3 Inflammasome Activation by MicroRNA-495 Promoter Methylation May Contribute to the Progression of Acute Lung Injury.

Authors:  Youguo Ying; Yong Mao; Min Yao
Journal:  Mol Ther Nucleic Acids       Date:  2019-10-03       Impact factor: 8.886

4.  GADD45B Is a Potential Diagnostic and Therapeutic Target Gene in Chemotherapy-Resistant Prostate Cancer.

Authors:  Qiong Wang; Wanhua Wu; Ze Gao; Kaiwen Li; Shirong Peng; Huiyang Fan; Zhongqiu Xie; Zhenghui Guo; Hai Huang
Journal:  Front Cell Dev Biol       Date:  2021-08-19

5.  The relationship between chimeric RNAs and gene fusions: Potential implications of reciprocity in cancer.

Authors:  Justin Elfman; Lam-Phong Pham; Hui Li
Journal:  J Genet Genomics       Date:  2020-06-14       Impact factor: 5.723

6.  ZNF281/Zfp281 is a target of miR-1 and counteracts muscle differentiation.

Authors:  Sara Nicolai; Marco Pieraccioli; Artem Smirnov; Consuelo Pitolli; Lucia Anemona; Alessandro Mauriello; Eleonora Candi; Margherita Annicchiarico-Petruzzelli; Yufang Shi; Ying Wang; Gerry Melino; Giuseppe Raschellà
Journal:  Mol Oncol       Date:  2019-12-24       Impact factor: 6.603

7.  The landscape of chimeric RNAs in non-diseased tissues and cells.

Authors:  Sandeep Singh; Fujun Qin; Shailesh Kumar; Justin Elfman; Emily Lin; Lam-Phong Pham; Amy Yang; Hui Li
Journal:  Nucleic Acids Res       Date:  2020-02-28       Impact factor: 16.971

8.  Characterization of a Read-through Fusion Transcript, BCL2L2-PABPN1, Involved in Porcine Adipogenesis.

Authors:  Jiyuan Zhu; Zewei Yang; Wanjun Hao; Jiaxin Li; Liang Wang; Jiqiao Xia; Dongjie Zhang; Di Liu; Xiuqin Yang
Journal:  Genes (Basel)       Date:  2022-02-28       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.